News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GlucoLight Corporation Successfully Completes First Hypoglycemic ''Clamping'' Study of Sentris-100(TM)


8/22/2007 9:44:35 AM

BETHLEHEM, Pa.--(BUSINESS WIRE)--GlucoLight Corporation, a development-stage company focused on blood glucose monitoring in the acute care environment, today announced the successful conclusion of the company’s first hypoglycemic “clamping” study to evaluate its continuous, non-invasive glucose monitor, Sentris-100™.

Read at BioSpace.com

comments powered by Disqus
   
Diabetes

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES